Liabilities / Assets
82nd percentile
Higher debt load relative to assets than 82% of similar nonprofits.
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
82nd percentile
Higher debt load relative to assets than 82% of similar nonprofits.
Liabilities / Revenue
76th percentile
Higher debt load relative to revenue than 76% of similar nonprofits.
Net Margin
62nd percentile
Higher net margin than 62% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
25th percentile
Faster asset growth than 25% of similar nonprofits.
Revenue Growth
64th percentile
Faster revenue growth than 64% of similar nonprofits.
Assets
Down$446,759
Down $25,273 (-5.4%) from 2014
Net Assets
Up$236,222
Up $67,426 (+40%) from 2014
Liabilities
Down$210,537
Down $92,699 (-31%) from 2014
Revenue
Up$819,208
Up $80,000 (+11%) from 2014
Expenses
Down$751,782
Down $48,841 (-6.1%) from 2014
Net Income
Up$67,426
Up $128,841 (+210%) from 2014
This 2015 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
All activities for research and treatment of Cystic Fibrosis.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2015 • Form 990Summary only. Only limited summary data is available for this year.